Illumina, Inc.
Tagmentation using immobilized transposomes with linkers

Last updated:

Abstract:

The present disclosure relates to methods, compositions, and kits for treating target nucleic acids, including methods and compositions for fragmenting and tagging nucleic acid (e.g., DNA) using transposome complexes bound to a solid support.

Status:
Grant
Type:

Utility

Filling date:

20 Feb 2018

Issue date:

16 Feb 2021